Key Takeaways

GLP-1 drugs might protect people against sleep apnea

All type 2 diabetes patients who took GLP-1 drugs were less likely to die within a year

However, those with sleep apnea had an additional 20% lower risk of dying

TUESDAY, Oct. 21, 2025 (HealthDay News) — Weight-loss drugs like Ozempic and Zepbound might help protect people from health risks related to sleep apnea, a new study says.

Type 2 diabetes patients taking GLP-1 drugs were overall less likely to die within the next year, but those with sleep apnea did even better, researchers reported Monday at a meeting of the American College of Chest Physicians in Chicago.

“We observed one-year mortality in patients with type two diabetes who were prescribed GLP-1RAs to be substantially lower than patients not prescribed

See Full Page